RecruitingNCT07330362
The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Diagnosis System.
The Clinical Application of Artificial Intelligence Assisted Renal Biopsy Image Diagnosis System.
Sponsor
Zhujiang Hospital
Enrollment
2,900 participants
Start Date
Jul 1, 2024
Study Type
OBSERVATIONAL
Conditions
Summary
This research project aims to collect images from patients with chronic glomerulonephritis. For each subject, the images obtained from renal biopsy will undergo evaluation by both the diagnostic model and the 'gold standard' diagnosis by pathologists. The researchers will test the subjects using the diagnostic model and compare the results with the known 'gold standard' diagnosis, in order to evaluate the AUC, specificity, and sensitivity of the diagnostic model.
Eligibility
Min Age: 15 YearsMax Age: 79 Years
Inclusion Criteria3
- Voluntary signing of informed consent form;
- Patients clinically diagnosed or suspected of having chronic kidney disease according to the 2023 KDIGO Clinical Practice Guideline for the Evaluation and Management of Kidney Disease;
- Undergoing renal biopsy and pathological specimen preparation.
Exclusion Criteria2
- Biopsy tissue from donor kidney or transplanted kidney;
- Poor quality of pathological specimen, unable to conduct pathological diagnosis.
Locations(2)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07330362
Related Trials
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Chronic Kidney Disease
NCT06926660153 locations
A Study to Find Out How EMPAgliflozin is Tolerated and if it Helps Children and Adolescents With Chronic KIDNEY Disease (EMPA-KIDNEY® Kids)
NCT07107945102 locations
A Prospecitve Multicenter, Observational Registry Study
NCT074815261 location
Improving Kidney Care in Type 2 Diabetes: A Study of Pharmacist Prescribing Versus Usual Care
NCT071694221 location
An Observational Study Called FINE-REAL Korea to Learn More About the Use of the Drug Finerenone in People With Chronic Kidney Disease and Type 2 Diabetes in a Routine Medical Care Setting in South Korea
NCT072325371 location